Evaluation of cognitive behavioral therapy for drug use disorders in Indonesia
Not Applicable
Recruiting
- Conditions
- Substance use disorders
- Registration Number
- JPRN-UMIN000042186
- Lead Sponsor
- Psychiatric Department, University of Indonesia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1) having comorbidity of severe psychotic or physical disorder which hinder them from providing informed consent or participating in group therapy, and 2) using residential care.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of days of being abstinent from the primarily used drug during the past 30 days assessed by weekly-basis interviews and validated by urinalysis
- Secondary Outcome Measures
Name Time Method 1. Addiction severity assessed by the Addiction Severity Index (ASI) 2. Health-related quality of life assessed by the EuroQol-5D (EQ-5D-5L) 3. Motivation to change assessed by the Action subscale of the University of Rhode Island Change Assessment (URICA) 4. Coping strategies assessed by the Brief Coping Orientations to Problems Experienced (The Brief COPE) 5. Psychiatric symptoms assessed by the Symptom Checklist 90-R (SCL-90-R) 6. Cognitive function assessed by the Rey Auditory Verbal Learning Test (RAVLT) 7. Retention in treatment defined as at least 75 percent of the planned number of therapeutic contacts during the past 3 months 8. Treatment satisfaction assessed by the Client Satisfaction Questionnaire-3 (CSQ-3) 9. Group cohesion assessed by the Group Therapy Experience Scale (GTES)